Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies

Por Stasch, Johannes-Peter, Alonso-Alija, Cristina, Apeler, Heiner, Dembowsky, Klaus, Feurer, Achim, Minuth, Torsten, Perzborn, Elisabeth, Schramm, Matthias, Straub, Alexander
Publicado em 2002

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272

Por Becker, Eva Maria, Alonso-Alija, Cristina, Apeler, Heiner, Gerzer, Rupert, Minuth, Torsten, Pleiβ, Ulrich, Schmidt, Peter, Schramm, Matthias, Schröder, Henning, Schroeder, Werner, Steinke, Wolfram, Straub, Alexander, Stasch, Johannes-Peter
Publicado em 2001

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

Por Stasch, Johannes-Peter, Schmidt, Peter, Alonso-Alija, Cristina, Apeler, Heiner, Dembowsky, Klaus, Haerter, Michael, Heil, Markus, Minuth, Torsten, Perzborn, Elisabeth, Pleiss, Ulrich, Schramm, Matthias, Schroeder, Werner, Schröder, Henning, Stahl, Elke, Steinke, Wolfram, Wunder, Frank
Publicado em 2002

Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension

Por Mittendorf, Joachim, Weigand, Stefan, Alonso-Alija, Cristina, Bischoff, Erwin, Feurer, Achim, Gerisch, Michael, Kern, Armin, Knorr, Andreas, Lang, Dieter, Muenter, Klaus, Radtke, Martin, Schirok, Hartmut, Schlemmer, Karl-Heinz, Stahl, Elke, Straub, Alexander, Wunder, Frank, Stasch, Johannes-Peter
Publicado em 2009